IL136905A0 - Recombinant rhabdovirus containing a heterologous fusion protein - Google Patents
Recombinant rhabdovirus containing a heterologous fusion proteinInfo
- Publication number
- IL136905A0 IL136905A0 IL13690598A IL13690598A IL136905A0 IL 136905 A0 IL136905 A0 IL 136905A0 IL 13690598 A IL13690598 A IL 13690598A IL 13690598 A IL13690598 A IL 13690598A IL 136905 A0 IL136905 A0 IL 136905A0
- Authority
- IL
- Israel
- Prior art keywords
- fusion protein
- heterologous fusion
- recombinant rhabdovirus
- rhabdovirus containing
- recombinant
- Prior art date
Links
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20241—Use of virus, viral particle or viral elements as a vector
- C12N2760/20243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
- C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
- C12N2810/855—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from receptors; from cell surface antigens; from cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
- C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
- C12N2810/859—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6847297P | 1997-12-22 | 1997-12-22 | |
| PCT/US1998/026084 WO1999032648A1 (en) | 1997-12-22 | 1998-12-22 | Recombinant rhabdovirus containing a heterologous fusion protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL136905A0 true IL136905A0 (en) | 2001-06-14 |
Family
ID=22082797
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13690598A IL136905A0 (en) | 1997-12-22 | 1998-12-22 | Recombinant rhabdovirus containing a heterologous fusion protein |
| IL136905A IL136905A (en) | 1997-12-22 | 2000-06-20 | Recombinant rehab virus containing heterologous fusion protein |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL136905A IL136905A (en) | 1997-12-22 | 2000-06-20 | Recombinant rehab virus containing heterologous fusion protein |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6497873B1 (https=) |
| EP (1) | EP1040198B1 (https=) |
| JP (1) | JP4544497B2 (https=) |
| AP (1) | AP1968A (https=) |
| AT (1) | ATE451466T1 (https=) |
| AU (2) | AU752004B2 (https=) |
| BR (1) | BR9814370A (https=) |
| CA (1) | CA2316033A1 (https=) |
| DE (1) | DE69841372D1 (https=) |
| IL (2) | IL136905A0 (https=) |
| MX (1) | MXPA00006184A (https=) |
| NZ (1) | NZ505312A (https=) |
| OA (1) | OA11432A (https=) |
| WO (1) | WO1999032648A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL148621A0 (en) * | 1999-09-17 | 2002-09-12 | Pro Virus Inc | Oncolytic virus |
| AU2001281151A1 (en) * | 2000-08-24 | 2002-03-04 | Thomas Jefferson University | Rhabdovirus-based vectors to express high levels of functional human antibodies |
| WO2002072776A2 (en) * | 2001-03-09 | 2002-09-19 | The Regents Of The University Of California | Cell culture system for synthesis of infectious hepatitis c virus |
| CA2452517A1 (en) * | 2001-07-11 | 2003-01-23 | University Of Miami | Recombinant vsv for the treatment of tumor cells |
| US7820435B2 (en) * | 2002-02-06 | 2010-10-26 | Expression Technologies Inc. | De novo synthesized plasmid, methods of making and use thereof |
| US7731974B2 (en) | 2003-03-27 | 2010-06-08 | Ottawa Hospital Research Institute | Mutant vesicular stomatitis viruses and uses thereof |
| JP2007524363A (ja) | 2003-03-27 | 2007-08-30 | オタワ ヘルス リサーチ インスティチュート | 変異体水疱性口内炎ウイルスおよびそれらの使用 |
| KR20060017635A (ko) * | 2003-06-05 | 2006-02-24 | 와이어쓰 홀딩스 코포레이션 | 베네쥬엘라 말 뇌염 바이러스 레플리콘 벡터 및파라믹소바이러스 단백질 항원을 포함하는 면역원성 조성물 |
| EP1633860A2 (en) | 2003-06-09 | 2006-03-15 | Wyeth | IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| WO2009016433A2 (en) * | 2006-09-15 | 2009-02-05 | Ottawa Health Research Institute | Oncolytic rhabdovirus |
| US8961951B2 (en) * | 2007-07-06 | 2015-02-24 | Boyce Thompson Institute For Plant Research | Baculoviruses with enhanced virion production and a method for the production of baculoviruses |
| US8703469B2 (en) | 2007-07-06 | 2014-04-22 | Boyce Thompson Institute For Plant Research | Baculoviruses with enhanced virion production and a method for the production of baculoviruses |
| US20100215691A1 (en) | 2009-02-20 | 2010-08-26 | Parks Christopher L | Recombinant viral vectors |
| CA2789539A1 (en) | 2011-09-12 | 2013-03-12 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
| US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
| US9347065B2 (en) | 2012-03-29 | 2016-05-24 | International Aids Vaccine Initiative | Methods to improve vector expression and genetic stability |
| WO2013158263A1 (en) | 2012-04-18 | 2013-10-24 | Mayo Foundation For Medical Education And Research | Replication-competent vesicular stomatitis viruses |
| FR2996856B1 (fr) * | 2012-10-15 | 2015-06-05 | Agronomique Inst Nat Rech | Novirhabdovirus recombinant utilisable comme vecteur d'antigenes |
| AU2018261637A1 (en) * | 2017-05-03 | 2019-12-12 | Biomarin Pharmaceutical Inc. | Improved lentiviruses for transduction of hematopoietic stem cells. |
| US11274141B2 (en) | 2017-05-10 | 2022-03-15 | Wellstat Immunotherapeutics, Llc | Enveloped virus resistant to complement inactivation for the treatment of cancer |
| CN115768784A (zh) * | 2020-02-06 | 2023-03-07 | 勃林格殷格翰动物保健有限公司 | 用于检测抗弹状病毒抗体的多肽 |
| WO2023051607A1 (zh) * | 2021-09-29 | 2023-04-06 | 上海行深生物科技有限公司 | 病毒培养方法 |
-
1998
- 1998-12-22 JP JP2000525566A patent/JP4544497B2/ja not_active Expired - Fee Related
- 1998-12-22 MX MXPA00006184A patent/MXPA00006184A/es not_active IP Right Cessation
- 1998-12-22 IL IL13690598A patent/IL136905A0/xx active IP Right Grant
- 1998-12-22 BR BR9814370-0A patent/BR9814370A/pt not_active Application Discontinuation
- 1998-12-22 AT AT98963811T patent/ATE451466T1/de not_active IP Right Cessation
- 1998-12-22 NZ NZ505312A patent/NZ505312A/xx unknown
- 1998-12-22 WO PCT/US1998/026084 patent/WO1999032648A1/en not_active Ceased
- 1998-12-22 DE DE69841372T patent/DE69841372D1/de not_active Expired - Lifetime
- 1998-12-22 CA CA002316033A patent/CA2316033A1/en not_active Abandoned
- 1998-12-22 US US09/217,967 patent/US6497873B1/en not_active Expired - Fee Related
- 1998-12-22 EP EP98963811A patent/EP1040198B1/en not_active Expired - Lifetime
- 1998-12-22 AP APAP/P/2000/001852A patent/AP1968A/en active
- 1998-12-22 AU AU19056/99A patent/AU752004B2/en not_active Ceased
-
2000
- 2000-06-20 IL IL136905A patent/IL136905A/en not_active IP Right Cessation
- 2000-06-21 OA OA1200000184A patent/OA11432A/en unknown
-
2002
- 2002-07-19 AU AU2002300207A patent/AU2002300207B2/en not_active Ceased
- 2002-10-23 US US10/277,997 patent/US20030138457A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1040198B1 (en) | 2009-12-09 |
| IL136905A (en) | 2007-10-31 |
| AU2002300207B2 (en) | 2006-07-13 |
| AP1968A (en) | 2009-04-30 |
| AU1905699A (en) | 1999-07-12 |
| BR9814370A (pt) | 2000-10-10 |
| US20030138457A1 (en) | 2003-07-24 |
| WO1999032648A1 (en) | 1999-07-01 |
| AP2000001852A0 (en) | 2000-06-30 |
| US6497873B1 (en) | 2002-12-24 |
| JP4544497B2 (ja) | 2010-09-15 |
| MXPA00006184A (es) | 2003-02-11 |
| EP1040198A1 (en) | 2000-10-04 |
| OA11432A (en) | 2004-04-26 |
| DE69841372D1 (de) | 2010-01-21 |
| AU752004B2 (en) | 2002-09-05 |
| NZ505312A (en) | 2003-01-31 |
| ATE451466T1 (de) | 2009-12-15 |
| CA2316033A1 (en) | 1999-07-01 |
| JP2001526901A (ja) | 2001-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL136905A0 (en) | Recombinant rhabdovirus containing a heterologous fusion protein | |
| AU2002300207A1 (en) | Recombinant Rhabdovirus containing a heterologous Fusion Protein | |
| GB9718609D0 (en) | Fusion protein | |
| AU7274898A (en) | Recombinant antibody-enzyme fusion proteins | |
| IL132537A0 (en) | Truncated vegf-related proteins | |
| AU8182298A (en) | Recombinant erythropoietin / immunoglobulin fusion proteins | |
| ZA983234B (en) | Preparation of recombinant factor viii in a protein free medium | |
| HUP0200414A2 (en) | Interferon-betha fusion proteins and uses | |
| AU5065198A (en) | Fusion proteins having increased half-lives | |
| ZA976666B (en) | Fusion polypeptides | |
| GB9112553D0 (en) | Fusion proteins | |
| IL122898A0 (en) | Allergan -XCD32 fusion proteins | |
| GB9913437D0 (en) | Fusion proteins | |
| AU9798398A (en) | Gfp-annexin fusion proteins | |
| IL148550A0 (en) | Transgenically produced fusion proteins | |
| IL135942A0 (en) | Assay employing cadc fusion proteins | |
| HUP0004509A3 (en) | Proteinase inhibitor fusion proteins | |
| HU9502114D0 (en) | Expression system using autolysable fusion protein and new reducing polypeptides | |
| IL91462A0 (en) | Recombinant fusion proteins and dna encoding for such a protein | |
| AU4661697A (en) | Pfs28 fusion proteins | |
| GB9713150D0 (en) | Fusion proteins | |
| GB9603486D0 (en) | A high throughputassay using fusion proteins | |
| GB9707307D0 (en) | Polypeptide markers | |
| GB9726956D0 (en) | Protein binding polypeptides | |
| GB9811516D0 (en) | Fusion proteins having increased half-lives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |